Orchestra BioMed Holdings (OBIO) Return on Capital Employed (2022 - 2025)
Historic Return on Capital Employed for Orchestra BioMed Holdings (OBIO) over the last 4 years, with Q3 2025 value amounting to 1.42%.
- Orchestra BioMed Holdings' Return on Capital Employed fell 3700.0% to 1.42% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.42%, marking a year-over-year decrease of 3700.0%. This contributed to the annual value of 0.93% for FY2024, which is 3100.0% down from last year.
- As of Q3 2025, Orchestra BioMed Holdings' Return on Capital Employed stood at 1.42%, which was down 3700.0% from 2.1% recorded in Q2 2025.
- Orchestra BioMed Holdings' Return on Capital Employed's 5-year high stood at 0.37% during Q2 2023, with a 5-year trough of 2.1% in Q2 2025.
- In the last 4 years, Orchestra BioMed Holdings' Return on Capital Employed had a median value of 0.81% in 2024 and averaged 0.91%.
- Its Return on Capital Employed has fluctuated over the past 5 years, first crashed by -300bps in 2023, then tumbled by -11800bps in 2025.
- Quarter analysis of 4 years shows Orchestra BioMed Holdings' Return on Capital Employed stood at 0.51% in 2022, then dropped by -6bps to 0.54% in 2023, then crashed by -98bps to 1.08% in 2024, then plummeted by -31bps to 1.42% in 2025.
- Its last three reported values are 1.42% in Q3 2025, 2.1% for Q2 2025, and 1.32% during Q1 2025.